These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9420023)

  • 1. Nursing care strategies for the management of side effects in patients treated for colorectal cancer.
    Taplin SC; Blanke CD; Baughman C
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-64-S18-70. PubMed ID: 9420023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing toxicities associated with colorectal cancer chemotherapy and targeted therapy: a new guide for nurses.
    Grenon NN; Chan J
    Clin J Oncol Nurs; 2009 Jun; 13(3):285-96. PubMed ID: 19502186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer.
    Chiara S; Nobile MT; Gozza A; Taveggia P; Heouaine A; Pastrone I; Percivale PL; Lionetto R; Sanguineti O; Rosso R
    Anticancer Res; 2004; 24(1):355-60. PubMed ID: 15015621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating new data on colorectal cancer into nursing practice.
    Viale PH
    Clin J Oncol Nurs; 2010 Feb; 14(1):92-100. PubMed ID: 20118032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
    Marshall JL; Richmond E; DeLap RJ
    Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for treatment design: biochemical modulation of 5-fluorouracil by leucovorin.
    Rustum YM; Cao S; Zhang Z
    Cancer J Sci Am; 1998; 4(1):12-8. PubMed ID: 9467039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [10-hydroxy-camptothecin plus fluorouracil/leucovorin for the treatment of patients with advanced colorectal cancer].
    Zhang HG; Cai RG; Chen SS; Wu F; Chu DT
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1462-4. PubMed ID: 17785082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms.
    Kearney N; Miller M; Maguire R; Dolan S; MacDonald R; McLeod J; Maher L; Sinclair L; Norrie J; Wengström Y
    Eur J Oncol Nurs; 2008 Dec; 12(5):443-8. PubMed ID: 18842457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why nurses must get involved in colorectal cancer management.
    Melville A
    Nurs Times; 1998 Mar 18-24; 94(11):56-8. PubMed ID: 9697535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New chemotherapy treatment options and implications for nursing care.
    Berg DT
    Oncol Nurs Forum; 1997; 24(1 Suppl):5-12. PubMed ID: 9010860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
    Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
    J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives in the treatment of colorectal cancer.
    Ozer H; Diasio RB
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):14-8. PubMed ID: 15726534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing toxicities associated with antiangiogenic biologic agents in combination with chemotherapy for metastatic colorectal cancer.
    Grenon NN
    Clin J Oncol Nurs; 2013 Aug; 17(4):425-33. PubMed ID: 23899982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.